1-8 of 8
Yi He
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Rindopepimut with Bevacizumab for Patients with Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II Trial

David A. Reardon, Annick Desjardins, James J. Vredenburgh, Donald M. O'Rourke, David D. Tran, Karen L. Fink, Louis B. Nabors, Gordon Li, Daniela A. Bota, Rimas V. Lukas, Lynn S. Ashby, J. Paul Duic, Maciej M. Mrugala, Scott Cruickshank, Laura Vitale, Yi He, Jennifer A. Green, Michael J. Yellin, Christopher D. Turner, Tibor Keler, Thomas A. Davis, John H. Sampson
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (7): 1586–1594.
https://doi.org/10.1158/1078-0432.CCR-18-1140
Published: 01 April 2020
View article titled, Rindopepimut with Bevacizumab for Patients with Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II Trial
Open the PDF for Rindopepimut with Bevacizumab for Patients with Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II Trial in another window
Includes: Supplementary data
Journal Articles

The Phosphatase Inhibitor Menadione (Vitamin K3) Protects Cells from EGFR Inhibition by Erlotinib and Cetuximab

Roman Perez-Soler, Yiyu Zou, Tianhong Li, Yi He Ling
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (21): 6766–6777.
https://doi.org/10.1158/1078-0432.CCR-11-0545
Published: 31 October 2011
View article titled, The Phosphatase Inhibitor Menadione (Vitamin K3) Protects Cells from EGFR Inhibition by Erlotinib and Cetuximab
Open the PDF for The Phosphatase Inhibitor Menadione (Vitamin K3) Protects Cells from EGFR Inhibition by Erlotinib and Cetuximab in another window
Includes: Supplementary data
Journal Articles

PM02734 (Elisidepsin) Induces Caspase-Independent Cell Death Associated with Features of Autophagy, Inhibition of the Akt/mTOR Signaling Pathway, and Activation of Death-Associated Protein Kinase

Yi-He Ling, Miguel Aracil, Yiyu Zou, Ziqiang Yuan, Bo Lu, José Jimeno, Ana Maria Cuervo, Roman Perez-Soler
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (16): 5353–5366.
https://doi.org/10.1158/1078-0432.CCR-10-1948
Published: 14 August 2011
View article titled, PM02734 (Elisidepsin) Induces Caspase-Independent Cell Death Associated with Features of Autophagy, Inhibition of the Akt/mTOR Signaling Pathway, and Activation of Death-Associated Protein Kinase
Open the PDF for PM02734 (Elisidepsin) Induces Caspase-Independent Cell Death Associated with Features of Autophagy, Inhibition of the Akt/mTOR Signaling Pathway, and Activation of Death-Associated Protein Kinase in another window
Journal Articles

Schedule-Dependent Cytotoxic Synergism of Pemetrexed and Erlotinib in Human Non–Small Cell Lung Cancer Cells

Tianhong Li, Yi-He Ling, I. David Goldman, Roman Perez-Soler
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (11): 3413–3422.
https://doi.org/10.1158/1078-0432.CCR-06-2923
Published: 01 June 2007
View article titled, Schedule-Dependent Cytotoxic Synergism of Pemetrexed and Erlotinib in Human Non–Small Cell Lung Cancer Cells
Open the PDF for Schedule-Dependent Cytotoxic Synergism of Pemetrexed and Erlotinib in Human Non–Small Cell Lung Cancer Cells in another window
Journal Articles

Enhanced Sensitivity to the HER1/Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Erlotinib Hydrochloride in Chemotherapy-Resistant Tumor Cell Lines

Qun Dai, Yi-He Ling, Marie Lia, Yi-Yu Zou, Glenn Kroog, Kenneth K. Iwata, Roman Perez-Soler
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (4): 1572–1578.
https://doi.org/10.1158/1078-0432.CCR-04-0993
Published: 02 March 2005
View article titled, Enhanced Sensitivity to the HER1/Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Erlotinib Hydrochloride in Chemotherapy-Resistant Tumor Cell Lines
Open the PDF for Enhanced Sensitivity to the HER1/Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Erlotinib Hydrochloride in Chemotherapy-Resistant Tumor Cell Lines in another window
Journal Articles

Mechanisms of Proteasome Inhibitor PS-341-induced G2-M-Phase Arrest and Apoptosis in Human Non-Small Cell Lung Cancer Cell Lines

Yi-He Ling, Leonard Liebes, Jian-Dong Jiang, James F. Holland, Peter J. Elliott, Julian Adams, Franco M. Muggia, Roman Perez-Soler
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (3): 1145–1154.
Published: 01 March 2003
View article titled, Mechanisms of Proteasome Inhibitor PS-341-induced G<sub>2</sub>-M-Phase Arrest and Apoptosis in Human Non-Small Cell Lung Cancer Cell Lines
Open the PDF for Mechanisms of Proteasome Inhibitor PS-341-induced G<sub>2</sub>-M-Phase Arrest and Apoptosis in Human Non-Small Cell Lung Cancer Cell Lines in another window
Journal Articles

Response and Determinants of Sensitivity to Paclitaxel in Human Non-Small Cell Lung Cancer Tumors Heterotransplanted in Nude Mice

Roman Perez-Soler, Bonnie Kemp, Qing Ping Wu, Li Mao, Jorge Gomez, Anne Zeleniuch-Jacquotte, Herman Yee, Jin Soo Lee, Jaishree Jagirdar, Yi He Ling
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (12): 4932–4938.
Published: 01 December 2000
View article titled, Response and Determinants of Sensitivity to Paclitaxel in Human Non-Small Cell Lung Cancer Tumors Heterotransplanted in Nude Mice
Open the PDF for Response and Determinants of Sensitivity to Paclitaxel in Human Non-Small Cell Lung Cancer Tumors Heterotransplanted in Nude Mice in another window
Journal Articles

EGF Receptor and p21WAF1 Expression are Reciprocally Altered as ME-180 Cervical Carcinoma Cells Progress from High to Low Cisplatin Sensitivity

Nicholas J. Donato, Margot Perez, Hyunseok Kang, Zahid H. Siddik, Yi-He Ling, Roman Perez-Soler
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (1): 193–202.
Published: 01 January 2000
View article titled, EGF Receptor and p21WAF1 Expression are Reciprocally Altered as ME-180 Cervical Carcinoma Cells Progress from High to Low Cisplatin Sensitivity
Open the PDF for EGF Receptor and p21WAF1 Expression are Reciprocally Altered as ME-180 Cervical Carcinoma Cells Progress from High to Low Cisplatin Sensitivity in another window